logo
Channel 10 star Barry Du Bois reveals harrowing moment he was given ‘three months to live'

Channel 10 star Barry Du Bois reveals harrowing moment he was given ‘three months to live'

News.com.au2 days ago

Channel 10 presenter Barry Du Bois has penned an emotional essay about his ongoing cancer battle, revealing a doctor once told him he had 'three months to live'.
The father of two was first diagnosed in 2010 with solitary plasmacytoma, a rare form of blood cancer.
That diagnosis later progressed to myeloma in 2017, which is an incurable cancer that affects the immune system and attacks bone marrow.
'I was sitting in a cold, unfamiliar consult room at the hospital, my wife's hand holding mine … then a doctor who had known me for only a few hours looked me in the eye and told me I had three months to live,' he penned in letter for The Gold Coast Bulletin, recalling his earlier diagnosis.
It wasn't the first time the presenter has had to deal with medical setbacks.
He had previously broken his back after falling 14 metres from a roof, and later went through years of failed IVF treatment with his wife, Leonie, which included a miscarriage and her own cancer diagnosis just two weeks later.
He credits all those personal battles to his ongoing cancer fight, continuing to spend as much time with his beloved family as possible.
'When I got my diagnosis – incurable cancer, three months to live – I didn't fall apart … I knew that from leaning into the previous adversities of life I had the resilience to give the fight of my life,' Du Bois said.
But that hadn't always been the case. After his wife's miscarriage and cancer diagnosis, Du Bois initially struggled to find a way to go on.
'I avoided conversation and started a continual negative conversation with myself that took me into the darkness … depression is a lonely state and I refused to share my pain. I saw it as a weakness.'
But in the end his family helped to pull him through, and he's since used the positive outlook to give him the strength to keep going.
Du Bois first appeared on Aussie screens in 2011 as a contestant on The Renovators, before joining Amanda Keller, Dr Chris Brown and Miguel Maestre as a co-host on The Living Room.
He's been very vocal about his cancer journey over the last decade, regularly sharing inspiring updates and honest confessions on his social media platforms with fans as he continues to beat his initial devastating prognosis handed to him.
'I was overwhelmed with fear, uncertainty, and the unknown,' he said earlier this year of his diagnosis.
'But through it all, I realised something that I feel is why I am here today: It wasn't going to be cancer that defined me but the way I choose to approach it.'

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Celebrate NAIDOC Week with ABC's  That Blackfella Show
Celebrate NAIDOC Week with ABC's  That Blackfella Show

ABC News

time16 minutes ago

  • ABC News

Celebrate NAIDOC Week with ABC's That Blackfella Show

Celebrate NAIDOC Week with ABC's That Blackfella Show The ABC is thrilled to announce Australia's first First Nations variety program, That Blackfella Show will premiere Saturday 5 July at 7.30pm on ABC TV and ABC iview. Broadcasting live in front of a studio audience, celebrate an hour of laughs, yarns and music this NAIDOC week. Hosted by Australian icon Ernie Dingo, ABC News Breakfast host Bridget Brennan and introducing Isaac Compton as their studio sidekick, it's set to be a big, blak night of entertainment. The showcase will feature a stellar line up of guests and First Nation stars including Steph Tisdell, Dane Simpson, Abbie Chatfield, Jimmy Barnes, Outback Tom, BARKAA, Kevin Kropinyeri and many more. Featuring performances of iconic black anthems from the award winning Aboriginal Australian music duo Electric Fields, Maningrida all-female rock band The Ripple Effect Band and ARIA-nominated singer, songwriter, rapper Miss Kaninna. It's loud, it's proud, it's a variety hour not to be missed. Always free and always entertaining, discover and celebrate Indigenous stories and features on ABC iview now. PRODUCTION CREDIT: An Australian Broadcasting Corporation Production. Executive Producer: Rowdie Walden. ABC Head of Indigenous: Kelrick Martin.

EMVision adds Ramsay Health Care boss to board
EMVision adds Ramsay Health Care boss to board

The Australian

time17 minutes ago

  • The Australian

EMVision adds Ramsay Health Care boss to board

Ramsay Health Care Australia CEO Carmel Monaghan joins board of EMVision Medical Devices Monaghan has worked across hospital, corporate and global positions at Ramsay for almost three decades Appointment comes as EMVision progresses pivotal trial for emu bedside brain scanner to diagnose stroke Special Report: The CEO of Ramsay Health Care, Australia's largest private hospital operator, has joined the board of EMVision Medical devices as a non-executive director. With her appointment effective today, Carmel Monaghan, who has been CEO of Ramsay Health Care (ASX:RHC) Australia since 2020, joins the board of EMVision Medical Devices (ASX:EMV) at a pivotal time in its commercial journey. Ramsay is Australia's largest private hospital operator and offers a range of multidisciplinary healthcare services. It also has extensive operations internationally including in the UK and Europe. Monaghan has worked across hospital, corporate and global positions at Ramsay for almost three decades. Before her appointment as CEO, Monaghan was group chief of staff of Ramsay's global operations, gaining extensive experience and a comprehensive understanding of healthcare operations and strategy both in Australia and overseas. EMVision said she also served as the group head of marketing and public affairs, driving marketing, brand and communications strategy, during which time the group grew to become a leading private healthcare operator globally. Appointment follows start of pivotal trial Monaghan's appointment comes after the company kicked off a pivotal trial in March for its first commercial device – the emu bedside brain scanner, which is designed to rapidly diagnose stroke at the point-of-care. The pivotal trial supports US Food and Drug Administration (FDA) de novo (new device) clearance for emu. If granted clearance emu is anticipated to become the predicate device for its second device, First Responder, allowing an expedited 510(k) FDA pathway for the pre-hospital market. EMVision this week announced it had broadened the pivotal trial for its first commercial device with activation at Mount Sinai Hospital in New York, scheduled for this month. Mount Sinai is recognised as a leader in stroke research and treatment. Activation of another site – Liverpool Hospital in Sydney, is in progress this Hospital is recognised as one of the largest stroke referral centres in New South Wales. All up, five world-leading hospitals are now taking part in EMVision's pivotal trial with a sixth set to be activated shortly. Watch: EMVision expands trial for bedside stroke scanner A 'transformative opportunity' Monaghan said she looks forward to working with management and fellow directors as the company enters a pivotal phase in its commercialisation journey. 'After more than three decades in healthcare leadership, I'm especially drawn to opportunities where innovation directly addresses unmet patient needs,' she said. 'Stroke and traumatic brain injury are leading causes of global disability and disease burden and will increase with an ageing population. 'Timely access to acute care and treatment are crucial in minimising the impact of stroke and so I'm excited by the transformative opportunity that EMVision's point-of-care neurodiagnostic products represent to improve outcomes for patients.' EMVision chairman John Keep said Monaghan was an 'exceptional addition' to EMVision's board. 'She brings a wealth of experience across clinician engagement, corporate strategy, marketing, procurement and government relations,' he said. 'With our pivotal trial for regulatory clearance underway, the board looks forward to Carmel's contributions as EMVision progresses through to commercialisation and growth.' This article does not constitute financial product advice. You should consider obtaining independent advice before making any financial decisions.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store